目前治疗腺菌症的医疗疗法:从长椅到床边
Andrea Etrusco1,2, Fabio Barra3,4, Vito Chiantera1,5
1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
Drugs
|October 14, 2023
概括
腺菌症的治疗是复杂的,症状缓解的选择有限. 需要研究以提供基于证据的指导方针,以改善患者的生活质量和生育结果.
科学领域:
- 妇科 妇科 妇科 妇科
- 生殖医学 生殖医学
- 医学研究 医学研究
背景情况:
- 腺肌症涉及子宫内膜组织在子宫壁的生长,导致严重的治疗挑战.
- 目前的治疗常常集中在异常的子宫出血 (AUB) 和经期不良,而NSAIDs和tranexamic acid的疗效有限.
- 腺肌症经常与子宫内膜异位症和子宫乳腺瘤共存,使诊断和治疗决策复杂化.
研究的目的:
- 审查当前的腺髓炎医疗管理策略.
- 突出现有疗法的局限性,并确定未来研究的领域.
- 强调需要基于证据的指导方针来改善患者的治疗结果.
主要方法:
- 对腺肌症当前治疗选择的文献综述.
- 激素和非激素治疗的疗效和局限性的分析.
- 讨论诊断复杂性和对生活质量和生育能力的影响.
主要成果:
- 利沃诺格斯特勒释放性子宫内系统 (LNG-IUS) 和二氧化 (DNG) 是有前途的,但缺乏标准化指南.
- 达纳有副作用,而联合口服避孕药 (COC) 可能效果较差.
- 淋巴激素释放激素 (GnRH) 激动剂可以控制症状,但会引起更年期的副作用;GnRH抗剂和芳香酶抑制剂 (AI) 需要进一步研究.
结论:
- 由于证据有限和治疗选择有限,有效的腺髓炎医疗管理仍然具有挑战性.
- 进一步的研究对于制定标准化指导方针,了解生育结果和探索新的治疗点至关重要.
- 优化治疗策略和建立基于证据的指导方针对于改善腺髓炎患者的护理和生活质量至关重要.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
183
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
183
01:17Drugs for Treatment of Diarrhea-Predominant IBS
188
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
188